LDRI Seminar - Prof. Sander RENSEN
-
Wednesday, 16 September 2026, 13h00Wednesday, 16 September 2026, 14h00
Wednesday, September 16, 2026 – 1pm – Salle De Visscher (74.00)
Prof. Sander Rensen - Maastricht University, Nederland
Organoid approaches to study the clinical relevance of tumor-host interactions in cancer cachexia
Related publications :
• Inflammation-associated intramyocellular lipid alterations in human pancreatic cancer cachexia. Deng M, Cao J, van der Kroft G, van Dijk DPJ, Aberle MR, Grgic A, Neumann UP, Wiltberger G, Balluff B, Schaap FG, Heeren RMA, Olde Damink SWM, Rensen SS. J Cachexia Sarcopenia Muscle. 2024;15:1283-1297. doi: 10.1002/jcsm.13474
• Human pancreatic tumour organoid-derived factors enhance myogenic differentiation. Vaes RDW, van Dijk DPJ, Farshadi EA, Olde Damink SWM, Rensen SS*, Langen RC*. J Cachexia Sarcopenia Muscle. 2022;13:1302-1313. doi: 10.1002/jcsm.12917
• Antibody-dependent cellular cytotoxicity-inducing antibodies enhance the natural killer cell anti-cancer response against patient-derived pancreatic cancer organoids. Beelen NA, Aberle MR, Bruno V, Olde Damink SWM, Bos GMJ, Rensen SS*, Wieten L*. Front Immunol. 2023 Jul 14;14:1133796. doi: 10.3389/fimmu.2023.1133796